Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of GuangXi Medical UniversityNo recent work listed

Chengkun Yang

Matched on ORCID iD 0000-0001-6109-7334; OpenAlex author ID A5032874546. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 5 papers · 2020: 4 papers · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 14

  1. Comprehensive analysis of LILR family genes expression and tumour-infiltrating immune cells in early-stage pancreatic ductal adenocarcinoma. Co-author DOI 10.1049/syb2.12058↗
  2. UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodene… Co-author DOI 10.7150/jca.46084↗
  3. Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential… Co-author DOI 10.1002/cam4.2699↗
  4. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms. Co-author DOI 10.1186/s12876-020-01560-0↗
  5. Investigation of the association between C-X-C motif chemokine receptor subunits and tumor infiltration levels and prognosis in patients with early-stage pancr… First author DOI 10.3892/ol.2020.11877↗
  6. Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early s… Co-author DOI 10.7150/jca.39888↗
  7. Prognostic value of Kinesin-4 family genes mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy. Co-author DOI 10.1002/cam4.2524↗
  8. Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/aging.102007↗
  9. Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2019.00511↗
  10. Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2019.7135↗
  11. Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after … Co-author DOI 10.3892/or.2019.7277↗
  12. Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Co-author DOI 10.2147/cmar.s168351↗
  13. Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy. Co-author DOI 10.2147/cmar.s171293↗
  14. Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Co-author DOI 10.2147/ott.s142557↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiwen Liao · 13 shared papers, 2017–2023 · strength 1.22
  2. Tao Peng · 13 shared papers, 2017–2023 · strength 1.22
  3. Xinping Ye · 8 shared papers, 2019–2023 · strength 0.82
  4. Xin Zhou · 6 shared papers, 2019–2021 · strength 0.56
  5. Quan‐Fa Han · 5 shared papers, 2018–2020 · strength 0.42
  6. Qiongyuan Wu · 3 shared papers, 2019–2020 · strength 0.32
  7. Junqi Liu · 3 shared papers, 2019–2020 · strength 0.25
  8. Liming Shang · 2 shared papers, 2019–2020 · strength 0.18
  9. Qiang Gao · 1 shared paper, 2023 · strength 0.16
  10. Long‐ming Lei · 1 shared paper, 2020 · strength 0.15
  11. Zijun Chen · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.